Home Blend Therapeutics Appoints Drew Fromkin as President and Chief Executive Officer
 

Keywords :   


Blend Therapeutics Appoints Drew Fromkin as President and Chief Executive Officer

2015-04-13 16:44:27| Biotech - Topix.net

Blend Therapeutics, Inc. , a biopharmaceutical company discovering and developing two distinct classes of targeted anti-cancer medicines to advance the treatment of patients with solid tumor cancers, announced today the appointment of Drew Fromkin as President and Chief Executive Officer and a member of the company's Board of Directors. Mr. Fromkin previously served as President and Chief Executive Officer of Clinical Data, Inc., until its acquisition by Forest Laboratories.

Tags: executive president chief officer

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
26.11GibsonSG
26.11Dimarzio DP419 area67 2
26.11110
26.11
26.11tnqnp671
26.11SchucoClassic
26.11 DX 3 25CM
26.112018
More »